AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 50 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $467,000 | +51.6% | 23,765 | +11.0% | 0.00% | +100.0% |
| Q2 2017 | $308,000 | +63.8% | 21,403 | +4.5% | 0.00% | 0.0% |
| Q1 2017 | $188,000 | -23.0% | 20,488 | -12.5% | 0.00% | 0.0% |
| Q4 2016 | $244,000 | +22.6% | 23,425 | +6.5% | 0.00% | 0.0% |
| Q3 2016 | $199,000 | +26.8% | 21,996 | +5.1% | 0.00% | 0.0% |
| Q2 2016 | $157,000 | -16.9% | 20,937 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $189,000 | -8.3% | 20,937 | +31.5% | 0.00% | 0.0% |
| Q4 2015 | $206,000 | +38.3% | 15,924 | +3.1% | 0.00% | 0.0% |
| Q3 2015 | $149,000 | -6.3% | 15,450 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $159,000 | +156.5% | 15,450 | +176.9% | 0.00% | – |
| Q1 2015 | $62,000 | -84.5% | 5,580 | -83.7% | 0.00% | -100.0% |
| Q4 2014 | $399,000 | +202.3% | 34,286 | +473.9% | 0.00% | +100.0% |
| Q3 2014 | $132,000 | -20.5% | 5,974 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $166,000 | – | 5,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |